A month of back-and-forth has resulted in a Takeda (NASDAQOTH:TKPHF) and Shire Plc(NASDAQ:SHPG) striking a deal to form the eight biggest drugmaker in the world. The merger's $62 billion cost, however, could be a problem, especially if it dings Takeda's credit rating.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,